Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Green

Showing results (301-310 of 433) with videos related to

Pageof 44
Sort By:
Mayo Clinic Proceedings|August 1, 1974
Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndromeR L Edelson, M A Lutzner, C H Kirkpatrick, et al.
Annals of the New York Academy of Sciences|February 28, 1975
Ir genes and antigen recognitionE M Shevach, F Finkelman, S Z Ben-Sasson, et al.
Schizophrenia Research|December 31, 2002
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidoneAlan I Green, Ellen S Burgess, Ree Dawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1995
Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular studyI Green, E Espiritu, M Ladanyi, et al.
Molecular Pharmacology|May 1, 1973
The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluoreneS S Thorgeirsson, D J Jollow, H A Sasame, et al.
Schizophrenia Bulletin|June 20, 2006
Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disordersMary F Brunette, Robert E Drake, Haiyi Xie, et al.
The Journal of Nervous and Mental Disease|April 1, 1998
Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological studyI Berman, A Merson, B Viegner, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective surveyS V Zimmet, R D Strous, E S Burgess, et al.
Lancet (London, England)|July 1, 1973
Two varieties of Sézary syndrome, both bearing T-cell markersM A Lutzner, R L Edelson, R W Smith, et al.
General Hospital Psychiatry|August 11, 2000
Weight gain from novel antipsychotic drugs: need for actionA I Green, J K Patel, R M Goisman, et al.
Pageof 44

Showing results (301-310 of 433) with videos related to

Sort By:
Pageof 44
Mayo Clinic Proceedings|August 1, 1974
Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndromeR L Edelson, M A Lutzner, C H Kirkpatrick, et al.
Annals of the New York Academy of Sciences|February 28, 1975
Ir genes and antigen recognitionE M Shevach, F Finkelman, S Z Ben-Sasson, et al.
Schizophrenia Research|December 31, 2002
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidoneAlan I Green, Ellen S Burgess, Ree Dawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1995
Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular studyI Green, E Espiritu, M Ladanyi, et al.
Molecular Pharmacology|May 1, 1973
The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluoreneS S Thorgeirsson, D J Jollow, H A Sasame, et al.
Schizophrenia Bulletin|June 20, 2006
Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disordersMary F Brunette, Robert E Drake, Haiyi Xie, et al.
The Journal of Nervous and Mental Disease|April 1, 1998
Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological studyI Berman, A Merson, B Viegner, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective surveyS V Zimmet, R D Strous, E S Burgess, et al.
Lancet (London, England)|July 1, 1973
Two varieties of Sézary syndrome, both bearing T-cell markersM A Lutzner, R L Edelson, R W Smith, et al.
General Hospital Psychiatry|August 11, 2000
Weight gain from novel antipsychotic drugs: need for actionA I Green, J K Patel, R M Goisman, et al.
Pageof 44